LMNX News and Press, Luminex Corporation From 03/11/21

Like most other manufacturers of diagnostic systems and test panels, Luminex has seen sales surge on COVID-19 pandemic demand. The new VERIGENE II platform offers improved system performance over the older generation, but menu expansion will be critical. The older ARIES platform c...

Luminex Corporation (LMNX) has applied for an Emergency Use Authorization from the FDA for a multi-analyte respiratory panel that combines Flu A/B and respiratory syncytial virus (“RSV”) targets with the SARS-CoV-2 target.The company says that the filing marks a key mi...

Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization PR Newswire AUSTIN, Texas , March 10, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an Emergency Use Authori...

Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference PR Newswire AUSTIN, Texas , March 9, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , Chairman, CEO & President, and Harr...

Luminex (LMNX) has received Emergency Use Authorization ((EUA)) from the FDA for a new expanded version of its NxTAG Respiratory Pathogen Panel ((RPP)) that includes the SARS-CoV-2 virus for high-throughput respiratory testing. The panel now includes 19 viral and 2 bacterial targets.The ...

Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2 Provides labs with high throughput, syndromic respiratory testing capabilities PR Newswire AUSTIN, Texas , March 4, 2021 /PRNewsw...

Luminex (LMNX), a maker of covid-19 testing kits, rose 8.5% after a report that that the company is exploring its options after getting takeover interest.No final decision has been if the company will go ahead with sale or remain a standalone, according to the Bloomberg report.Recall lat...

Luminex (LMNX) gained 6.7% after a report that DiaSorin SpA (DSRLF) is looking at an acquisition of the Covid-19 test kit maker.DiaSorin working with advisers to consider potential purchase, Bloomberg reported, citing people familiar.Recall Feb. 19, Luminex receives BARDA funding. ...

Luminex (LMNX) trades 1.5% higher after receiving $11.3M in funding from the Biomedical Advanced Research and Development Authority ((BARDA)).These funds will support the rapid development and validation of a respiratory panel combining Flu A/B & respiratory syncytial virus targ...

Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel ARIES® Assay will simultaneously detect influenza A/B, RSV, and SARS-CoV-2 in a single test, and could help accelerate testing and reduce supply p...